CR20110317A - Derivados bicíclicos de morfina-6-glucuronido, su preparación y su aplicación en terapéutica - Google Patents

Derivados bicíclicos de morfina-6-glucuronido, su preparación y su aplicación en terapéutica

Info

Publication number
CR20110317A
CR20110317A CR20110317A CR20110317A CR20110317A CR 20110317 A CR20110317 A CR 20110317A CR 20110317 A CR20110317 A CR 20110317A CR 20110317 A CR20110317 A CR 20110317A CR 20110317 A CR20110317 A CR 20110317A
Authority
CR
Costa Rica
Prior art keywords
preparation
morfina
glucuronido
therapeutics
application
Prior art date
Application number
CR20110317A
Other languages
English (en)
Inventor
Alain Dlubala
Isabelle Ripoche
Claire Trecant
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of CR20110317A publication Critical patent/CR20110317A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invención se refiere a derivados bicíclicos de morfina -6-glucurónido, a su preparación y a su utilización para el tratamiento y la prevención del dolor.
CR20110317A 2008-12-11 2011-06-07 Derivados bicíclicos de morfina-6-glucuronido, su preparación y su aplicación en terapéutica CR20110317A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806974A FR2939796B1 (fr) 2008-12-11 2008-12-11 Derives bicycliques de morphine-6-glucuronide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
CR20110317A true CR20110317A (es) 2011-10-18

Family

ID=41037668

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20110317A CR20110317A (es) 2008-12-11 2011-06-07 Derivados bicíclicos de morfina-6-glucuronido, su preparación y su aplicación en terapéutica

Country Status (32)

Country Link
US (1) US8440634B2 (es)
EP (1) EP2376511B1 (es)
JP (1) JP5616355B2 (es)
KR (1) KR20110091536A (es)
CN (1) CN102317302B (es)
AR (1) AR074578A1 (es)
AU (1) AU2009326907B2 (es)
BR (1) BRPI0923368A2 (es)
CA (1) CA2746701A1 (es)
CL (1) CL2011001401A1 (es)
CO (1) CO6382159A2 (es)
CR (1) CR20110317A (es)
EA (1) EA201170791A1 (es)
EC (1) ECSP11011107A (es)
ES (1) ES2470684T3 (es)
FR (1) FR2939796B1 (es)
HN (1) HN2011001614A (es)
IL (1) IL213380A (es)
MA (1) MA32954B1 (es)
ME (1) ME01147B (es)
MX (1) MX2011006251A (es)
MY (1) MY153779A (es)
NI (1) NI201100113A (es)
NZ (1) NZ593340A (es)
PE (1) PE20120231A1 (es)
SG (1) SG172070A1 (es)
SV (1) SV2011003937A (es)
TN (1) TN2011000277A1 (es)
TW (1) TW201026313A (es)
UA (1) UA104445C2 (es)
WO (1) WO2010067008A2 (es)
ZA (1) ZA201104389B (es)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766188A (en) 1971-06-28 1973-10-16 Yamanouchi Pharma Co Ltd Carbonyldioxymorphinan derivatives
GB9116909D0 (en) 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
GB2282758A (en) 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
AU723859B2 (en) * 1997-04-14 2000-09-07 Ufc Limited Morphine derivatives
PL342189A1 (en) * 1998-02-02 2001-05-21 Cenes Ltd Method of glycosiding 4,5-epoxymorphinan-6-oles
IL139773A0 (en) 1998-06-06 2002-02-10 Cenes Ltd Morphine-6-glucuronide synthesis
DE10161963A1 (de) * 2001-12-17 2003-07-03 Johannes Schuetz 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
DE10229842A1 (de) * 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
GB0218811D0 (en) * 2002-08-14 2002-09-18 Cenes Ltd Salts of morphine-6-glucuronide
FR2864082B1 (fr) * 2003-12-22 2006-03-10 Synt Em Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur
CA2568249C (en) * 2004-05-28 2014-12-09 Human Biomolecular Research Institute Synthesis of metabolically stable analgesics, pain medications and other agents
FR2907121B1 (fr) * 2006-10-12 2012-05-04 Neorphys Nouveaux derives morphiniques

Also Published As

Publication number Publication date
PE20120231A1 (es) 2012-04-04
FR2939796B1 (fr) 2010-12-17
CN102317302A (zh) 2012-01-11
EA201170791A1 (ru) 2012-01-30
SV2011003937A (es) 2012-01-20
CL2011001401A1 (es) 2011-10-28
SG172070A1 (en) 2011-07-28
AU2009326907A1 (en) 2011-06-30
MY153779A (en) 2015-03-13
EP2376511A2 (fr) 2011-10-19
US20110275580A1 (en) 2011-11-10
US8440634B2 (en) 2013-05-14
FR2939796A1 (fr) 2010-06-18
IL213380A0 (en) 2011-07-31
HN2011001614A (es) 2014-03-03
CN102317302B (zh) 2014-02-12
HK1163109A1 (en) 2012-09-07
WO2010067008A3 (fr) 2011-07-07
NZ593340A (en) 2012-12-21
EP2376511B1 (fr) 2014-03-12
MA32954B1 (fr) 2012-01-02
WO2010067008A2 (fr) 2010-06-17
JP2012511552A (ja) 2012-05-24
ZA201104389B (en) 2012-09-26
IL213380A (en) 2014-02-27
KR20110091536A (ko) 2011-08-11
UA104445C2 (uk) 2014-02-10
TN2011000277A1 (fr) 2012-12-17
BRPI0923368A2 (pt) 2019-09-24
TW201026313A (en) 2010-07-16
CA2746701A1 (fr) 2010-06-17
ES2470684T3 (es) 2014-06-24
NI201100113A (es) 2011-12-15
ECSP11011107A (es) 2011-07-29
AU2009326907B2 (en) 2016-05-26
MX2011006251A (es) 2011-11-18
JP5616355B2 (ja) 2014-10-29
AR074578A1 (es) 2011-01-26
CO6382159A2 (es) 2012-02-15
ME01147B (me) 2012-12-20

Similar Documents

Publication Publication Date Title
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
HN2011002406A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
CL2012001405A1 (es) Compuestos derivados de espiroindolinona-pirrolidinas; proceso de obtención; composicion farmaceutica; y uso en el tratamiento o profilaxis del cancer.
GT200800250A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
ECSP12012310A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
GT201400033A (es) Pirimidinas anilladas sustituidas y uso de las mismas
UY32427A (es) Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma
UY31228A1 (es) Ariloxazoles sustituidos y su uso
SV2015004969A (es) Imidazo[1,2-a]piridincarboxamidas aminosustituidas y su uso
CL2013000016A1 (es) Compuestos derivados de imidazopiridina; procedimiento de preparacion; composicion farmaceutica y su uso en el tratamiento del cancer.
ECSP11011459A (es) Composiciones sublinguales de dexmedetomidina y métodos de uso de ellas
BR112012013487A2 (pt) Composições de amantadina e métodos de uso
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
NI201100155A (es) Composiciones y métodos para el tratamiento prolongado con aminopiridinas
CO6290689A2 (es) Derivados de 1,2,3,4-tetrahidropirrolo[1,2]pirazina-6-carboxamidas y de 2,3,4,5-tetrahidropirrol[1,2][1,4]-diazepina -7-carboxamidas su preparacion y su aplicacion en terapeutica
MX2011013324A (es) Uso de derivados de oxindol sustituidos para el tratamiento y profilaxis del dolor.
CR20120166A (es) Composiciones y productos antimicrobianos
CR20110317A (es) Derivados bicíclicos de morfina-6-glucuronido, su preparación y su aplicación en terapéutica
UA44395U (ru) Применение тиоцетама в качестве диуретического средства с мягким мочегонным действием в комплексном лечении
CL2009001327A1 (es) Compuestos heterociclo derivados de 3-oxoisoindolin-1-carboxamida; composicion farmaceutica que comprende dichos compuestos; y uso en el tratamiento del dolor.
BR112012001258A2 (pt) 1h-quinazolina-2,4-dionas para uso no tratamento da lipofuscinose ceroide neuronal
CL2010001424A1 (es) Compuestos derivados de azacarbolinas; compuestos intermediarios; composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento del cancer.
CL2011002626A1 (es) Compuestos derivados de piperazina, como antagonistas del receptor p2y12; composicion farmaceutica que los contienen; y su uso en el tratamiento de trastornos vasculares oclusivos.
CL2008001216A1 (es) Compuestos derivados de pirazol-3-il-amino-pirimidina; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer.
CL2015000101A1 (es) Composicion para la higiene intima que comprende un regulador de ph, un componente hidratante y un componente selectivo para el crecimiento de la flora saprofita, tal como alfa-glucan oligosacarido; proceso para producirla; y su uso para la higiene intima .